Ultrastructural Localization of the Norepinephrine Transporter in Superficial and Deep Layers of the Rat Prelimbic Prefrontal Cortex and Its Spatial Relationship to Probable Dopamine Terminals

Journal of Comparative Neurology

Volumn 466, Issue 4, 2003, Pages 478-494

  Miner, Leeann H ^a   Schroeter, Sally ^b   Blakely, Randy D ^c   Sesack, Susan R ^a,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b PFIZER INC   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressants; Catecholamine; Depression

Indexed keywords

ANTIDEPRESSANT AGENT; CATECHOLAMINE; DOPAMINE; NORADRENALIN; NORADRENALIN TRANSPORTER; PEROXIDASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOPLASM; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG ACTIVITY; IMMUNOGOLD LABELING; LIMBIC CORTEX; MALE; NERVE FIBER; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAT; SYNAPSE;

ANIMALS; CYTOSOL; DOPAMINE; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; NEURAL PATHWAYS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PREFRONTAL CORTEX; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; SYMPORTERS; TYROSINE 3-MONOOXYGENASE;

EID: 0142139269     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.10898     Document Type: Article

References (103)

1. Acheson AL, Kapatos G, Zigmond MJ. 1981. The effects of phosphorylating conditions on tyrosine hydroxylase activity are influenced by assay conditions and brain region. Life Sci 28:1407-1420.
2. Aoki C, Go C-G, Venkatesan C, Kurose H. 1994. Perikaryal and synaptic localization of alpha2A-adrenergic receptor-like immunoreactivity. Brain Res 650:181-204.
3. Aoki C, Venkatesan C, Go C-G, Forman R, Kurose H. 1998. Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. Cereb Cortex 8:269-277.
4. Arnsten AFT. 1997. Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 11:151-162.
5. Aston-Jones G, Chaing C, Alexinsky T. 1991. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog Brain Res 88:501-520.
6. Axelrod J, Kopin IJ. 1969. The uptake, storage, release, and metabolism of noradrenaline in sympathetic nerves. Prog Brain Res 31:21-32.
7. Axt KJ, Molliver ME, Qian Y, Blakely RD. 1995. Subtypes of 5-HT axons differ in their expression of serotonin transporter. Soc Neurosci Abstr 21:865.
8. Beaudet A, Descarries L. 1978. The monoamine innervation of rat cerebral cortex: synaptic and nonsynaptic axon terminals. Neuroscience 3:851-860.
9. Beaudet A, Descarries L. 1984. Fine structure of monoamine axon terminals in cerebral cortex. In: Descarries L, Reader TR, Jasper HH, editors. Monoamine innervation of the cerebral cortex. New York: Liss. p 77-93.
10. Beckman ML, Quick MW. 1998. Neurotransmitter transporters: regulators of function and functional regulation. J Membr Biol 164:1-10.
11. Berger B, Thierry A-M, Tassin JP, Moyne MA. 1976. Dopaminergic innervation of the rat prefrontal cortex: a fluorescence histochemical study. Brain Res 106:133-145.
12. 5 dopamine receptors in primate brain. J Neurosci 15:7821-7836.
13. Berman KF, Weinberger DR. 1990. The prefrontal cortex in schizophrenia and other neuropsychiatric diseases: in vivo physiological correlates of cognitive deficits. Prog Brain Res 85:521-537.
14. Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, DeFelice J. 1998. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transport proteins. Biol Psychiatry 44:169-178.
15. Bonisch H, Brüss M. 1994. The noradrenaline transporter of the neuronal plasma membrane. Ann N Y Acad Sci 733:193-202.
16. Brown ER, Coker GT, O'Malley KL. 1987. Organization and evolution of the rat tyrosine hydroxylase gene. Biochemistry 26:5208-5212.
17. Burnette WB, Bailey MD, Kukoyi S, Blakely RD, Trowbridge CG, Justice JB Jr. 1996. Human norepinephrine transporter kinetics using rotating disk electrode voltammetry. Anal Chem 68:2932-2938.
18. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW. 2002. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:699-711.
19. Campbell DG, Hardie DG, Vulliet PR. 1986. Identification of the four phosphorylation sites in the N-terminal region of tyrosine hydroxylase. J Biol Chem 261:10489-10492.
20. Carlson JN, Visker KE, Nielsen DM, Keller RW Jr, Glick SD. 1996. Chronic antidepressant drug treatment reduces turning behavior and increases dopamine levels in the medial prefrontal cortex. Brain Res 707:122-126.
21. Cass WA, Gerhardt GA. 1995. In vivo assessment of dopamine uptake in rat medial prefrontal cortex: comparison with dorsal striatum and nucleus accumbens. J Neurochem 65:201-207.
22. Chan J, Aoki C, Pickel VM. 1990. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods 33:113-127.
23. Dazzi L, Spiga F, Pira L, Ladu S, Vacca G, Rivano A, Jentsch JD, Biggio G. 2001. Inhibition of stress- or anxiogenic-drug-induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs. J Neurochem 76:1212-1220.
24. Descarries L, Umbriaco D. 1995. Ultrastructural basis of monoamine and acetylcholine function in CNS. Semin Neurosci 7:309-318.
25. Devoto P, Flore G, Pani L, Gessa GL. 2001. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry 6:657-664.
26. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME. 1992. A functional anatomical study of unipolar depression. J Neurosci 12:3628-3641.
27. Dumartin B, Caillé I, Gonon F, Bloch B. 1998. Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists. J Neurosci 18:1650-1661.
28. Emson PC, Koob GF. 1978. The origin and distribution of dopamine-containing afferents to the rat prefrontal cortex. Brain Res 142:249-267.
29. Florin-Lechner SM, Druhan JP, Aston-Jones G, Valentino RJ. 1996. Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus. Brain Res 742:89-97.
30. Frazer A. 2000. Norepinephrine involvement in antidepressant action. J Clin Psychiatry 61(Suppl 10):25-30.
31. Fritz JD, Jayanthi LD, Thoreson MA, Blakely RD. 1998. Cloning and chromosomal mapping of the murine norepinephrine transporter. J Neurochem 70:2241-2251.
32. Fuster JM. 1997. The prefrontal cortex: anatomy, physiology and neuropsychology of the frontal lobe. New York: Lippincott-Raven.
33. Garris PA, Wightman RM. 1994. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltametric study. J Neurosci 14:442-450.
34. Garris PA, Collins LB, Jones SR, Wightman RM. 1993. Evoked extracellular dopamine in vivo in the medial prefrontal cortex. J Neurochem 61:637-647.
35. Garzon M, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. 1999. Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporter. J Comp Neurol 410:197-210.
36. Gresch PJ, Sved AF, Zigmond MJ, Finlay JM. 1995. Local influences of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 65:111-116.
37. Gu HH, Wall S, Rudnick G. 1996. Ion coupling stoichiometry for the norepinephrine transporter in membrane vesicles from stably transfected cells. J Biol Chem 271:6911-6919.
38. Haycock JW. 1990. Involvement of serine-31 in phosphorylation of tyrosine hydroxylase in PC12 cells. J Biol Chem 265:11682-11691.
39. Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI. 1997. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388:211-227.
40. Hertel P, Nomikos GG, Svensson TH. 1999. Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level. Eur J Pharmacol 371:153-158.
41. Hillman H, Deutsch K. 1978. Area changes in slices of rat brain during preparation for histology or electron microscopy. J Microsc 114:77-84.
42. Hoffman BJ, Hansson SR, Mezey E, Palkovits M. 1998. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Front Neuroendocrinol 19:187-231.
43. Horn AS. 1973. Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurons in rat brain homogenates. Br J Pharmacol 47:332-338.
44. Hsu S-M, Raine L, Fanger H. 1981. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 29:577-580.
45. Ichikawa S, Sasaoka T, Nagatsu T. 1991. Primary structure of mouse tyrosine hydroxylase deduced from its cDNA. Biochem Biophys Res Commun 176:1610-1616.
46. Iversen LL. 1971. Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41:571-591.
47. Joh TH, Reis DJ. 1975. Different forms of tyrosine hydroxylase in central dopaminergic and noradrenergic neurons and sympathetic ganglia. Brain Res 85:146-151.
48. Jordan S, Kramer GL, Zukar PK, Moeller M, Petty F. 1994. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Synapse 18:294-297.
49. Kapur S, Austin MC, Underwood MD, Arango V, Mann JJ. 1993. Electroconvulsive shock increases tyrosine hydroxylase and neuropeptide Y gene expression in the locus coeruleus. Brain Res 18:121-126.
50. Kent JM. 2000. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet 355:911-918.
51. Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, Ordway GA. 1997. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 17:8451-8458.
52. Kosofsky BE, Molliver ME. 1987. The serotonergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse 1:153-168.
53. Krettek JE, Price JL. 1977. The cortical projections of the mediodorsal nucleus and adjacent thalamic nuclei in the rat. J Comp Neurol 171: 157-192.
54. Kumer SC, Vrana KE. 1996. Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67:443-462.
55. Lee A, Wissekerke AE, Rosin DL, Lynch KR. 1998. Localization of alpha2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system. Neuroscience 84:1085-1096.
56. Lewis DA, Campbell MJ, Foote SL, Goldstein M, Morrison JH. 1987. The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific. J Neurosci 7:279-290.
57. Lewis DA, Foote SL, Goldstein M, Morrison JH. 1988. The dopaminergic innervation of monkey prefrontal cortex: a tyrosine hydroxylase immunocytochemical study. Brain Res 449:225-243.
58. Li X-M, Perry KW, Wong DT, Bymaster FP. 1998. Olanzepine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology 136:153-161.
59. Lorang D, Amara SG, Simerly RB. 1994. Cell-type-specific expression of catecholamine transporters in the rat brain. J Neurosci 14:4903-4914.
60. Loughlin SE, Foote SL, Fallon JH. 1982. Locus coeruleus projections to cortex: topography, morphology and collateralization. Brain Res Bull 9:287-294.
61. Mamounas LA, Mullen CA, O'Hearn E, Molliver ME. 1991. Dual serotonergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J Comp Neurol 314:558-586.
62. Matsumoto M, Yoshioka M, Togashi H, Mori K, Ueno K, Saito H. 1998. Effects of idazoxan on dopamine release in the prefrontal cortex of freely moving rats. Eur J Pharmacol 343:165-170.
63. Miner LAH, Schroeter S, Blakely RD, Sesack SR. 2000. Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals. J Comp Neurol 427:220-234.
64. Möller H-J. 2000. Are all antidepressants the same? J Clin Psychiatry 61(Suppl 6):24-27.
65. Mostofsky SH, Cooper KL, Kates WR, Denckla MB, Kaufmann WE. 2002. Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder. Biol Psychiatry 52:785-794.
66. Mundorf ML, Joseph JD, Austin CM, Caron MG, Wightman RM. 2001. Catecholamine release and uptake in the mouse prefrontal cortex. J Neurochem 79:130-142.
67. Nelson JC. 1999. A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression. Biol Psychiatry 46:1301-1308.
68. Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. 1996. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16:436-447.
69. Nirenberg MJ, Chan J, Liu Y, Edwards RH, Pickel VM. 1997. Vesicularmonoamine transporter-2: immunogold localization in striatal axons and terminals. Synapse 26:194-198.
70. Noack HJ, Lewis DA. 1989. Antibodies directed against tyrosine hydroxylase differentially recognize noradrenergic axons in monkey neocortex. Brain Res 500:313-324.
71. Nutt DJ, Lalies MD, Lione LA, Hudson AL. 1997. Noradrenergic mechanisms in the prefrontal cortex. J Psychopharmacol 11:163-168.
72. Page ME, Lucki I. 2002. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex. Neuropsychopharmacology 27:237-247.
73. Pickel VM, Chan J. 1999. Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens. J Neurosci 19:7356-7366.
74. Pickel VM, Joh TH, Reis D. 1975a. Immunohistochemical localization of tyrosine hydroxylase in brain by light and electron microscopy. Brain Res 85:295-300.
75. Pickel VM, Joh TH, Field PM, Becker CG, Reis DJ. 1975b. Cellular localization oftyrosine hydroxylase by immunocytochemistry. J Histochem Cytochem 23:1-12.
76. Pickel VM, Joh TH, Reis DJ. 1975c. Ultrastructural localization oftyrosine hydroxylase in noradrenergic neurons of brain. Proc Natl Acad Sci U S A 72:659-663.
77. Raiteri M, Del Carmine R, Bertollini A, Levi G. 1977. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol 41:133-143.
78. Reis D, Joh TH, Ross RA, Pickel VM. 1974. Reserpine selectively increases tyrosine hydroxylase and dopamine-beta-hydroxylase enzyme protein in central noradrenergic neurons. Brain Res 81:380.
79. Reis DJ, Ross RA, Pickel VM, Lewander T, Joh TH. 1975. Some differences in tyrosine hydroxylase in central noradrenergic and dopaminergic neurons. In: Almgren O, Carlsson A, Engel J, editors. Chemical tools in catecholamine research. Vol. II. Oxford: North Holland. p 53-60.
80. Sands SA, Strong R, Corbitt J, Morilak DA. 2000. Effects of acute restraint stress on tyrosine hydroxylase mRNA expression in locus coeruleus of Wistar and Wistar-Kyoto rats. Mol Brain Res 75:1-7.
81. Schmidt RH, Bhatnagar RK. 1979. Assessment of the effects of neonatal subcutaneous 6-hydroxydopamine on noradrenergic and dopaminergic innervation of the cerebral cortex. Brain Res 166:309-319.
82. Schroeter S, Apparsundaram S, Wiley RG, Miner LAH, Sesack SR, Blakely RD. 2000. Immunolocalization of the cocaine- and antidepressant-sensitive 1-norepinephrine transporter. J Comp Neurol 420:211-232.
83. Séguéla P, Watkins KC, Geffard M, Descarries L. 1990. Noradrenaline axon terminals in adult rat neocortex: an immunocytochemical analysis in serial thin sections. Neuroscience 35:249-264.
84. Serova LI, Nankova BB, Feng A, Hong J-S, Hutt M, Sabban EL. 1999. Heightened transcription for enzymes involved in norepinephrine biosynthesis in the rat locus coeruleus by immobilization stress. Biol Psychiatry 45:853-862.
85. Sesack SR, Snyder CL, Lewis DA. 1995. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol 363:264-280.
86. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI. 1998. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18:2697-2708.
87. Shimada S, Kitayama S, Walther D, Uhl G. 1992. Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Mol Brain Res 13:359-362.
88. 1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc Natl Acad Sci U S A 91:5720-5724.
89. Soares JC, Mann JJ. 1997. The functional neuroanatomy of mood disorders. J Psychiatr Res 31:393-432.
90. Steinbusch HWM, Tilders FJH. 1987. Immunohistochemical techniques for light-microscopical localization of dopamine, noradrenaline, serotonin and histamine in the central nervous system. In: Steinbusch HWM, editor. Monoaminergic neurons: light microscopy and ultrastructure. New York: John Wiley and Sons. p 125-166.
91. Swanson LW, Hartman BK. 1975. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-B-hydroxylase as a marker. J Comp Neurol 163:467-487.
92. Tanda GL, Carboni E, Frau R, DiChiara G. 1994. Increase of extracellular dopamine in the prefrontal cortex: portrait of drugs with antidepressant potential? Psychopharmacology 115:285-288.
93. Tanda G, Frau R, DiChiara G. 1996. Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex. Psychopharmacology 127:83-87.
94. Tanda G, Pontier FE, Frau R, DiChiara G. 1997. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9:2077-2085.
95. Trendelenburg U. 1989. The uptake and metabolism of 3H-catecholamines in rat cerebral cortex slices. Naunyn Schmiedebergs Arch Pharmacol 339:293-297.
96. Vanhatalo S, Soinila S. 1995. Release of false transmitter serotonin from the dopaminergic nerve terminals of the rat pituitary intermediate lobe. Neurosci Res 22:367-374.
97. Veznedaroglu E, Milner TA. 1992. Elimination of artifactual labeling of hippocampal mossy fibers seen following pre-embedding immunogold-silver technique by pretreatment with zinc chelator. Microsc Res Tech 23:100-101.
98. Westerink BHC, de Boer P, de Vries JB, Kruse CG, Long SK. 1998. Antipsychotic drugs induce similar effects on the release of dopamine and norepinephrine in the medial prefrontal cortex of the rat brain. Eur J Pharmacol 361:27-33.
99. Wolf ME, LeWitt PA, Bannon MJ, Dragovic LJ, Kapatos G. 1991. Effect of aging on tyrosine hydroxylase protein content and the relative number ofdopamine nerve terminals in human caudate. J Neurochem 56:1191-1200.
100. Yamamoto BK, Novotney S. 1998. Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem 71:274-280.
101. Zagon A, Totterdell S, Jones RSG. 1994. Direct projections from the ventrolateral medulla oblongata to the limbic forebrain: anterograde and retrograde tract-tracing studies in the rat. J Comp Neurol 340:445-468.
102. Zigmond RE, Schon F, Iversen LL. 1974. Increased tyrosine hydroxylase activity in the locus coeruleus of rat brain stem after reserpine treatment and cold stress. Brain Res 70:547-552.
103. Zigmond MJ, Finlay JM, Sved AF. 1995. Neurochemical studies of central noradrenergic responses to acute and chronic stress. In: Friedman M, Charney D, Deutch A, editors. Neurobiological and clinical consequences of stress: from normal adaptations to PTSD. Philadelphia: Lippincott-Raven Publishers. p 45-60.